On October 5, 2025, a new clinical study was highlighted examining the comparative effectiveness of low-dose laser therapy and transcutaneous electrical nerve stimulation (TENS) in managing hemiplegic shoulder pain. This investigation, sponsored by Ankara Etlik City Hospital, aims to provide clarity on device-based interventions for patients experiencing pain associated with hemiplegia.
This study is currently recruiting participants, as listed on ClinicalTrials.gov, and seeks to contribute valuable data to both clinical teams and regulatory bodies.
- What changed?
- Focus on the devices: Low-dose laser and TENS
- Clinical study details
- Frequently Asked Questions
- Conclusion
- Disclaimer
- Announcement Details
What changed?
Hemiplegic shoulder pain is a common yet complex complication for individuals recovering from stroke or other neurological conditions. Managing this pain effectively remains a challenge due to the multifaceted nature of the condition. However, this new clinical trial is expected to shed light on two promising therapeutic devices: low-dose laser therapy and TENS.
In particular, the trial aims to evaluate these technologies’ ability to relieve pain when combined with conventional physical therapy. Results from this study could inform future recommendations for clinical practice and device adoption in pain management protocols for hemiplegia.
Focus on the devices: Low-dose laser and TENS
Low-dose laser therapy
Low-dose laser therapy uses focused light energy to stimulate biological tissues in a non-invasive manner. This approach targets inflammation and promotes healing. By enhancing microcirculation and cellular repair, it is increasingly being considered for managing chronic pain conditions, including those associated with immobilization or neurological trauma.
Transcutaneous Electrical Nerve Stimulation (TENS)
TENS involves delivering controlled electrical pulses through the skin to interfere with pain signals transmitted to the brain. Widely used in both clinical and home settings, this method seeks to alleviate chronic pain and is often approved for medical use under stringent regulatory frameworks.
Conventional physical therapy
Physical therapy remains a cornerstone of hemiplegic shoulder pain management. Its goals include improving mobility, decreasing stiffness, and enhancing overall shoulder joint functionality. Combining device-based interventions like TENS and laser therapy with physical therapy could optimize outcomes.
Clinical study details
The study, sponsored by Ankara Etlik City Hospital, aims to explore new avenues for improving care standards. Participants will receive treatment comprising one of the following interventions:
- Low-dose laser therapy
- TENS
- Conventional physical therapy
The trial intends to collect quantitative and qualitative data to evaluate which device offers superior effectiveness in reducing pain and improving quality of life for patients with hemiplegic shoulder conditions.
This effort aligns with the broader global push for enhanced rehabilitation approaches in neuromuscular and neurological care, supporting the objectives of modern regulatory and medical device standards.
Frequently Asked Questions
- Who can participate in the study? Individuals with hemiplegic shoulder pain are eligible to participate. Interested parties should contact Ankara Etlik City Hospital for more details.
- What is the purpose of the clinical trial? The trial aims to compare the efficacy of low-dose laser therapy and TENS, in combination with conventional physical therapy, for treating hemiplegic shoulder pain.
- How do low-dose laser and TENS therapies work? Low-dose laser therapy uses concentrated light to repair tissue and reduce inflammation, while TENS applies electrical impulses to block pain signals.
- Are these devices regulated by medical authorities? Both low-dose lasers and TENS are subject to regulatory approval and oversight, ensuring their safety and efficacy for clinical use.
Conclusion
The ongoing clinical trial could pave the way for more effective treatments for hemiplegic shoulder pain. It is particularly relevant for professionals and teams focusing on medical device regulations, quality assurance, and clinical treatment strategies. Monitoring the results of studies like this is essential to understanding and advancing treatment protocols.
Disclaimer
This article is a professional informational resource and does not constitute legal advice. Regulatory and clinical professionals should consult expertise specific to their needs.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07203222?term=medical+device